Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: Key quarterly highlights from Biogen’s Q4 2021 financial results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today.
Total revenue decreased 4% year-over-year to $2.73 billion.
GAAP net income attributable to Biogen Inc. was $368 million, or $2.50 per share, compared to $358 million, or $2.32 per share, last year. Adjusted net income was $500 million, or $3.39 per share.
For the full year of 2022, Biogen expects revenue to range between $9.7-10 billion and adjusted EPS to range between $14.25-16.00.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is expected to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
